Literature DB >> 21830268

Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea.

Byong Duk Ye1, Suk-Kyun Yang, Sun-Jin Boo, Yun Kyung Cho, Dong-Hoon Yang, Soon Man Yoon, Kyung Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Chang Sik Yu, Sung-Cheol Yun, Jin-Ho Kim.   

Abstract

BACKGROUND: Primary sclerosing cholangitis (PSC) is well known as one of the extraintestinal manifestations of ulcerative colitis (UC). However, the prevalence of PSC in UC patients together with the clinical characteristics and outcomes of UC associated with PSC (UC-PSC) are not clear in Asians.
METHODS: We retrospectively reviewed the medical records of UC patients who were registered and followed up at the Asan Medical Center. The prevalence of PSC in UC and the clinical features of UC-PSC compared with matched UC without PSC were investigated.
RESULTS: A total of 1849 patients diagnosed with UC between July 1977 and September 2009 were reviewed. Among these, 21 UC-PSC patients (1.1%) were identified. The cumulative probability of PSC after diagnosis of UC was 0.71% after 1-5 years, 1.42% after 10 years, 2.59% after 15 years, and 3.35% after 20-25 years. Compared with 63 matched UC alone patients, UC-PSC showed pancolitis (95.2%), rectal sparing (38.1%), and backwash ileitis (42.9%) more frequently (P < 0.001). During follow-up, three of 21 UC-PSC patients (14.3%) were diagnosed with colorectal neoplasia and three patients (14.3%) died of PSC-associated complications. UC-PSC patients were associated with increased probability of colorectal neoplasia development (P = 0.036) and a trend toward increased mortality compared with the UC alone group.
CONCLUSIONS: The prevalence of PSC in Korean UC patients appears to be lower than that of Western patients. Similar to Caucasians, UC-PSC shows unique colonoscopic features and is associated with more frequent colorectal neoplasia development and poor prognosis in Korea.
Copyright © 2010 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21830268     DOI: 10.1002/ibd.21569

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  21 in total

1.  Risk factors and clinical courses of concomitant primary sclerosing cholangitis and ulcerative colitis: a Korean multicenter study.

Authors:  Yong Eun Park; Jae Hee Cheon; Jae Jun Park; Yoon Jae Kim; Chang Hwan Choi; Yehyun Park; Soo Jung Park; Tae Il Kim; Won Ho Kim
Journal:  Int J Colorectal Dis       Date:  2018-07-09       Impact factor: 2.571

2.  Does the Intestinal Microbiota Explain Differences in the Epidemiology of Liver Disease between East and West?

Authors:  Nobuhiro Nakamoto; Bernd Schnabl
Journal:  Inflamm Intest Dis       Date:  2016-01-20

Review 3.  Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.

Authors:  A Boudewijn de Vries; Marcel Janse; Hans Blokzijl; Rinse K Weersma
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

4.  Atypical distribution of inflammation in newly diagnosed ulcerative colitis is not rare.

Authors:  Sang Hyoung Park; Suk-Kyun Yang; Soo-Kyung Park; Jong Wook Kim; Dong-Hoon Yang; Kee Wook Jung; Kyung-Jo Kim; Byong Duk Ye; Jeong-Sik Byeon; Seung-Jae Myung; Jin-Ho Kim
Journal:  Can J Gastroenterol Hepatol       Date:  2014-03

Review 5.  The IBD and PSC Phenotypes of PSC-IBD.

Authors:  Amanda Ricciuto; Binita M Kamath; Anne M Griffiths
Journal:  Curr Gastroenterol Rep       Date:  2018-03-28

6.  Steroid-refractory ulcerative colitis and associated primary sclerosing cholangitis treated with infliximab.

Authors:  Ileana Duca; Patricia Ramírez de la Piscina; Silvia Estrada; Rosario Calderón; Katerina Spicakova; Leire Urtasun; Carlos Marra-López; Salvador Zabaleta; Raquel Bengoa; María Asunción Marcaide; Francisco García-Campos
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

7.  Extraintestinal manifestations in inflammatory bowel disease: Prevalence and predictors in Indian patients.

Authors:  Debottam Bandyopadhyay; Sanjay Bandyopadhyay; Parasar Ghosh; Abhishek De; Anupam Bhattacharya; G K Dhali; Kshaunish Das
Journal:  Indian J Gastroenterol       Date:  2015-11-28

Review 8.  A review of the medical treatment of primary sclerosing cholangitis in the 21st century.

Authors:  Elizabeth C Goode; Simon M Rushbrook
Journal:  Ther Adv Chronic Dis       Date:  2016-01       Impact factor: 5.091

9.  Clinical characteristics and treatment of inflammatory bowel disease: a comparison of Eastern and Western perspectives.

Authors:  Soo Jung Park; Won Ho Kim; Jae Hee Cheon
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 10.  Ulcerative Colitis with and without Primary Sclerosing Cholangitis: Two Different Diseases?

Authors:  Atsushi Tanaka; Joachim C Mertens
Journal:  Inflamm Intest Dis       Date:  2016-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.